December 6, 2020

NEW DELHI (Reuters) – Pfizer Inc has applied for emergency use authorisation of its coronavirus vaccine in India, media said on Sunday, the first to do so in a country with the world’s second-highest number of infections.

The U.S. company, whose vaccine was recently approved by the British government, has written to the Drugs Controller General of India (DCGI), CNN-News18 reported citing a government source.

Officials at the DCGI and the health ministry did not respond to requests for comment. A government official, however, told Reuters that no application had been received as of Saturday night.

Pfizer could not immediately be reached.

Indian officials have said they are pinning their hopes mainly on locally tested vaccines instead of those developed by Pfizer and Moderna Inc.

The Pfizer shot needs to be stored at minus 70 degrees Celsius (-94 F) or below, temperatures that most Indian cold storages cannot reach.

India has reported more 9.57 million COVID-19 cases, behind only the United States, with nearly 140,000 deaths.

(Reporting by Mayank Bhardwaj, Devjyot Ghoshal, Neha Arora; Editing by Clarence Fernandez and William Mallard)

The post Pfizer seeks emergency approval for COVID-19 vaccine in India, media say first appeared on One America News Network.

Public Affairs

Sign Up for Our Newsletters

Get notified first!

You May Also Like

Newsom Recall Shows States Can Do More to Protect Constitutional Rights: Dr. Cordie Williams

It’s a ‘shot across the bow’ of politicians who would restrict civic…

Texas State Senate Passes Election Integrity Bill Targeting Mail-in Ballots

The Republican-led Texas state Senate passed a bill early on Thursday that…

Grassroots Rebellion Grows With New Calls to Ban Critical Race Theory from Military, Public Schools

Kevin O’Leary said he was “devastated” when he learned his former football…

Psaki Dodges Question About Laid-Off Pipeline Workers, Green Jobs

White House press secretary Jen Psaki on Monday dodged a question from…